Active substances
Benzoyl peroxide + Clindamycin
- SFDA 1
- US FDA 21
- Health Canada 4
- US price lines 2
- NHS prices 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Lustra | 1,3 %,% | Gel · Topical | 1 Tube | SAR 37.80 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DUAC | 5%;1.2% | gel · topical | STIEFEL | Prescription | 26 Aug 2002 |
| ACANYA | 2.5%;EQ 1.2% BASE | gel · topical | BAUSCH | Prescription | 23 Oct 2008 |
| ONEXTON | 3.75%;EQ 1.2% BASE | gel · topical | BAUSCH | Prescription | 23 Oct 2008 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;EQ 1% BASE | gel · topical | MYLAN PHARMS INC | Prescription | 11 Aug 2009 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;1.2% | gel · topical | PADAGIS ISRAEL | Prescription | 26 Jun 2012 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;EQ 1% BASE | gel · topical | PADAGIS ISRAEL | Prescription | 21 Sep 2015 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;EQ 1% BASE | gel · topical | ENCUBE | Prescription | 27 Jun 2017 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;1.2% | gel · topical | SUN PHARMA CANADA | Prescription | 15 Dec 2017 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;EQ 1% BASE | gel · topical | SUN PHARMA CANADA | Prescription | 25 May 2018 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 3.75%;EQ 1.2% BASE | gel · topical | SUN PHARMA CANADA | Prescription | 5 Jun 2018 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;1.2% | gel · topical | ZYDUS PHARMS | Prescription | 28 Dec 2018 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;EQ 1% BASE | gel · topical | GLENMARK SPECLT | Prescription | 14 Mar 2019 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 2.5%;EQ 1.2% BASE | gel · topical | SUN PHARMA CANADA | Prescription | 19 Aug 2019 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 2.5%;EQ 1.2% BASE | gel · topical | ENCUBE | Prescription | 19 Aug 2019 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 2.5%;EQ 1.2% BASE | gel · topical | PADAGIS ISRAEL | Prescription | 9 Sep 2019 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;1.2% | gel · topical | ENCUBE | Prescription | 28 Apr 2021 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 3.75%;EQ 1.2% BASE | gel · topical | PADAGIS ISRAEL | Prescription | 20 Aug 2024 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 3.75%;EQ 1.2% BASE | gel · topical | ACTAVIS LABS UT INC | Prescription | 7 Aug 2026 |
| BENZACLIN | 5%;EQ 1% BASE | gel · topical | BAUSCH | Discontinued | 21 Dec 2000 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 2.5%;EQ 1.2% BASE | gel · topical | ACTAVIS LABS UT INC | Discontinued | 19 Jun 2015 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 5%;1.2% | gel · topical | CHARTWELL RX | Discontinued | 25 Aug 2016 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BENZACLIN | 02248472 | 1 % / W/W; 5 % / W/W | GEL · TOPICAL | BAUSCH HEALTH, CANADA INC. |
| CLINDOXYL ADV GEL | 02382822 | 3 % / W/W; 1 % / W/W | GEL · TOPICAL | GLAXOSMITHKLINE INC |
| TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT | 02464519 | 1 % / W/W; 5 % / W/W | GEL · TOPICAL | TARO PHARMACEUTICALS INC |
| TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL | 02440180 | 5 % / W/W; 1 % / W/W | GEL · TOPICAL | TARO PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CLINDAMYCIN-BENZOYL PEROX 1-5% | $0.7423 | per GM | 23 Sep 2026 |
| US NADAC | CLINDAMYCIN-BENZOYL PEROX 1-5% | $0.50073 | per GM | 23 Sep 2026 |
| NHS Drug Tariff | Benzoyl peroxide 3% / Clindamycin 1% gel | £13.14 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Benzoyl peroxide 5% / Clindamycin 1% gel | £13.14 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Benzoyl peroxide 5% / Clindamycin 1% gel | £26.28 | 60 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.